Skip to main content


Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Fig. 1

Marginal effects plot of the model explaining the relationship between fasting glucose levels and CVD risk at baseline and at 12 months. On the X-axis, the logarithm of the fasting plasma glucose levels is represented for baseline (red) and for month 12 (blue). The Y-axis represents the CVD risk in scale 0–1. P-value refers to the interaction between fasting plasma glucose levels and month

Back to article page